Hi all
Yesterday I had the first face to face consultation since the pandemic. I must say I was wary of the reasons for this but went along anyway. The consultant reported that my blood tests results were unchanged and stable and the pegasys had reduced my spleen size by 0.7cm.
He said that I am quite symptomatic but my DIPSS score is still Int1 and therefore I am not eligible for ruxolitinib. He offered me the option of a drug trial but that would then rule me out for a stem cell transplant in the medium term.
He said that he feels that the time is right to think about SCT now as I am currently quite fit and healthy, all things considered, and in his opinion the Covid situation in the UK is pretty much under control now and would be less of a risk to the success of the transplant. He feels that because of the ASXL mutation my condition will only progress and the symptoms increase going forward.
I have to go back to see him in 4 weeks and come to a decision about whether to go ahead I’m finding life just about tolerable at present (although this could be partly due to lockdown fatigue) but dread the thought of my condition getting worse. I think I am leaning more towards the SCT but with a 60% 5 year survival rate it does make me worry, although my current prognosis is about 80 months from diagnosis without the SCT.
The next 4 weeks are going to require a lot of thought and research before I make my decision so any words of wisdom from this fantastic knowledgeable community will be greatly received.
Garry